Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

New Developments in SERS for the Pharmaceutical Industry

With advances in surface enhanced Raman scattering (SERS) technology, the accepted advantages of Raman analysis specificity, speed of measurement, application to aqueous systems and ease of sampling can now be transferred to a range of pharmaceutical applications that were previously the domain of HPLC and GCMS techniques.

Ewen Smith, Graeme McNay, David Eustace, Alastair McInroy and Karen Fitchett, Renishaw Diagnostics Ltd (September 2010)

Keywords: surface enhanced Raman scattering (SERS) technology Raman analysis specificity speed measurement, application aqueous systems sampling transferred pharmaceutical applications HPLC GCMS techniques

    View full article    |    Back to Analytical Laboratory Technology section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |